KR970032820A - 자외선 차단제를 함유하는 피부상처 치료제의 제조방법 - Google Patents
자외선 차단제를 함유하는 피부상처 치료제의 제조방법 Download PDFInfo
- Publication number
- KR970032820A KR970032820A KR1019950047411A KR19950047411A KR970032820A KR 970032820 A KR970032820 A KR 970032820A KR 1019950047411 A KR1019950047411 A KR 1019950047411A KR 19950047411 A KR19950047411 A KR 19950047411A KR 970032820 A KR970032820 A KR 970032820A
- Authority
- KR
- South Korea
- Prior art keywords
- benzophenone
- wound healing
- mixing
- paba
- ultraviolet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
본 발명은 피부의 상처를 치료능이 우수한 조성물의 제조방법에 관한 것이고, 이 제조방법은 베이스 성분; 자외선 산란제와 자외선 흡수제로 된 자외선 차단체; 상처치유제 및 물을 함유하는 상처 치유제 조성물의 제조방법에 있어서, (a) 베이스 성분과 자외선 흡수제를 혼합하여 가열하여 용융하는 단계; (b)단계 (a)에서 얻은 용융 혼합물에 자외선 산란제를 첨가하여 혼합하는 단계; (c) 물을 70~90℃로 가열한 후 상기 (b) 단계의 혼합물에 첨가하여 혼합하는 단계; 및 (d) 상기 (c) 단계에서 얻은 혼합물에 상처 치유제를 첨가하여 혼합하는 단계를 포함하는 것을 특징으로 한다.
상기 방법에 의해 얻어진 조성물은 물리화학적 물성이 상이한 자외선 차단제와 상처 치유제 성분이 잘 혼합되어 피부 상처에 사용시 효과적인 피부 상처 치유효과를 나타낸다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 베이스 성분; 자외선 산란제와 자외선 흡수제로 된 자외선 차단제; 상처 치유제 및 물을 함유하는 상처 치유제 조성물의 제조방법에 있어서, 하기 단계; (a) 베이스 성분과 자외선 흡수제를 혼합하여 가열하에 용융하는 단계; (b) 단계(a)에서 얻은 용융 혼합물에 자외선 산란제를 첨가하여 혼합하는 단계; (c) 물을 70~90℃로 가열한 후 상기 (b) 단계의 혼합믈에 첨가하여 혼합하는 단계 ; 및 (d) 상기 (c) 단계에서 얻은 혼합물에 상처 치유제를 첨가하여 혼합하는 단계를 포함하는 특징으로 하는 상처 치유제 조성물의 제조방법.
- 제1항에 있어서, 상기 자외선 흡수제는 알란토인 파바(allantoin PAPB), 3,4-메틸벤질리덴 캄포(3,4-Methylbenzylidene Camphor), 시녹세이트(Chinoxate), DEA-메톡시신나메이트(DEA-Methoxycinnamate), 옥토크릴렌(Octocrylene) 벤조페논-1(Benzophenone-1), 벤조페논-2(Benzophenone-2), 벤조페논-3(Benzophenone-3), 벤조페논-4(Benzophenone-4), 벤조페논-5(Benzophenone-5), 벤노페논-6(Benzophenone-6), 벤조페논-7(Benzophenone-7), 벤조페논-8(Benzophenone-8), 벤조페논-11(Benzophenone-11), 옥트리졸(Octrizole), 옥틸디 메칠 파바(Octyl Dimethyl PABA), 옥틸메톡시신나메이트(Octyl Methoxycinnamate), 에칠 디하드록시프로필 파바(Ethyl Dihydroxypropyl PABA), 파바(PABA), PEG-25 파바(PEG-25 PABA), 펜틸디메칠 파바(Pentyl Dimethyl PABA), 페닐벤지미다졸설포닉애씨드(Phenylbenzimidazole Sulfonic Acie). 글리세릴 파바(Glyceryl PABA). 글리콜실리케이트(Glycolsalicylate), 소디움유로케네이트(Sodium Urocanate), 벤조페논-12(Benzophenone-12), 호모살레이트(Homosalate), TEA-살리실레이트(TEA-Salicylate), 3-벤조페논캄포(3-Benzophenone Camphor), 이소아밀 파라-메톡시신나메이트(Isoamyl P-Methoxycinnamate), 벤질살리실레이트(Benzyl Salicylate), 이소프로필벤질살리실레이트(Isopropylbenzyl Salicyiate). 유로켄산(Urocanic Acid). 이소프로필메톡시신나메이트(Isopropyl Methozycinnamate), 및 부틸메톡시벤조일메탄(Butyl methoxydibenzoylmethane)에서 선택된 1종 또는 2종 이상의 것임을 특징으로 하는 방법.
- 제1항에 있어서, 상기 자외선 산란제는 탈크(talc), 이산회티탄(titanium dioxide), 산화 아연(zinc oxide), 및 카올린(kaolin) 에서 선택된 1종 또는 2종 이상임을 특징으로 하는 방법.
- 제1항에 있어서, 상기 상처 치유제는 센텔라 아시아티카 추출물(centella asiatica extract), 소디움 후시데이트(sodium fusidate), 히드로코티존 아세테이트(hydrocortisone acetate), 텍사판텐놀(dexapathenol). 알란토인(allantoin), 네오마이신 셀페이트(neomycin sulfate), 젠타마이신(gentamicin sulfate), 박시트라신(bacitracin), 폴리미신 비 셀페이트(Polymyxin B sulfate), 니트로후라존(nitro furazone), 및 옥시테트라사이클린 염산(oxytetracycline HCI)에서 선택된 1종 또는 2종 이상임을 특징으로 하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950047411A KR0153202B1 (ko) | 1995-12-07 | 1995-12-07 | 자외선 차단제를 함유하는 피부상처 치료제의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950047411A KR0153202B1 (ko) | 1995-12-07 | 1995-12-07 | 자외선 차단제를 함유하는 피부상처 치료제의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970032820A true KR970032820A (ko) | 1997-07-22 |
KR0153202B1 KR0153202B1 (ko) | 1998-11-16 |
Family
ID=19438266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950047411A KR0153202B1 (ko) | 1995-12-07 | 1995-12-07 | 자외선 차단제를 함유하는 피부상처 치료제의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0153202B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102470802B1 (ko) | 2021-11-24 | 2022-11-28 | 재영티에스(주) | 어스앵커용 천공장치 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102004208B1 (ko) * | 2017-10-30 | 2019-07-29 | 주식회사 애니테이프 | 자외선 차단 기능이 있는 하이드로-콜로이드 핫멜트 습윤성 드레싱 테이프의 제조 방법 |
-
1995
- 1995-12-07 KR KR1019950047411A patent/KR0153202B1/ko not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102470802B1 (ko) | 2021-11-24 | 2022-11-28 | 재영티에스(주) | 어스앵커용 천공장치 |
Also Published As
Publication number | Publication date |
---|---|
KR0153202B1 (ko) | 1998-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0165329B1 (en) | Liquid detergent with sunscreen agent | |
US5744125A (en) | Cosmetic melanins | |
WO2017034367A2 (ko) | 표면 개질용 조성물 | |
WO2015088126A1 (ko) | 카르보디이미드계 화합물을 포함하는 조성물 | |
PL316416A1 (en) | Pharmaceutic agent exhibiting immunoregulating and psychotropic properties, therapeutic form thereof and method of treating diseases of immunological and physical background | |
CA2298238A1 (en) | Controlled release by extrusion of solid amorphous dispersions of drugs | |
CA2214884A1 (en) | Poly(hydroxy acid)/polymer conjugates for skin applications | |
JP2002506099A (ja) | 酵素阻害剤 | |
EP0921819A4 (en) | CANCER TREATMENT AND PREVENTION THROUGH DERIVATIVES OF HUMAN CHORIO-GONADOTROPINE | |
JP2003522726A (ja) | 着色した毛髪を処理する化粧方法 | |
CA2391343A1 (en) | Skin care composition | |
US4933174A (en) | Method of using a liquid detergent with sunscreen agent | |
EP1090642A3 (en) | Vaccines comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein | |
NO20010593L (no) | Preparat og fremgangsmÕte for behandling av Peyronies sykdom og andre subdermale plakkmanifestasjonsforstyrrelser | |
WO1996025920A9 (en) | Cosmetic melanins | |
DE69418601D1 (de) | Guanidinderivate mit therapeutischer wirkung | |
EP0996412A1 (en) | Sunscreen composition | |
DE69907802T2 (de) | Thermisch wirkende Pflaster und seiner Verwendung | |
KR970032820A (ko) | 자외선 차단제를 함유하는 피부상처 치료제의 제조방법 | |
EP0749753A3 (en) | Use of a powder or an extract of guava for treating allergic diseases | |
US5240715A (en) | Color modified melanins and methods for their preparation and use | |
US5188844A (en) | Color modified melanins and methods for their preparation and use | |
EP1736170A3 (en) | Agent for treating allergic or hypersensitivity condition | |
US5486353A (en) | Antisun product | |
CA2234936A1 (en) | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20040607 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |